Mode
Text Size
Log in / Sign up
N/A Completed N=197 Double-blind Health Services Research

CASA: Care and Support Access in HIV Disease

Source: ClinicalTrials.gov NCT02136680 ↗
Enrolled (actual)
197
Serious AEs
0.0%
Results posted
Feb 2019
Primary outcomePrimary: Mental Health: Rosenberg Self-Esteem Scale — 3.2; 3.2; 3.2; 3.1 [Units on a scale] — p=0.400

Summary

This is an investigator-initiated study to measure the impact of an educational intervention on the basic palliative approach for a multidisciplinary staff team at an outpatient HIV clinic. The study aims to: 1) refine a curriculum for non-palliative care clinicians caring for persons living with HIV disease early in the disease trajectory; 2) assess the impact of the palliative approach educational intervention on outcomes for 2 target populations: a) patients (mental health, quality of life, health-related quality of life and secondarily, retention in care and viral suppression) and b) staff (burn-out and caregiving stress). It is hypothesized that training outpatient HIV staff in palliative care competencies will improve care provided that might, in turn, improve clinical outcomes for HIV patients receiving care at that clinic. Quantitative data will be augmented by qualitative interviews of selected staff and patients at both clinics in the final year of the study to appreciate response to the intervention.

Outcome Measures

OutcomeResultp-value
PRIMARY
Mental Health: Rosenberg Self-Esteem Scale
3.2; 3.2; 3.2; 3.1; 3.1; 3.0 0.400
PRIMARY
Quality of Life: McGill Quality of Life Scale
6.9; 6.7; 7.0; 6.9; 7.3; 7.1 0.959
PRIMARY
Health-Related Quality of Life in Palliative Care: Palliative Outcome Scale
8.9; 8.4; 8.4; 9.5; 8.5; 8.5 0.213
SECONDARY
Viral Load Suppressed
43; 32; 59; 52; 25; 20
SECONDARY
Adherence
53; 39; 59; 45; 42; 41

Eligibility Criteria

PATIENTS -

Inclusion Criteria

  • HIV positive
  • men who have sex with men attending one of 2 study site clinics
  • 18-35 years

Exclusion Criteria

  • acute illness requiring medical attention
  • cognitive impairment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02136680). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search